Rankings
▼
Calendar
PLRX Q4 2019 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PLRX
Pliant Therapeutics, Inc.
$82M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$57M
Gross Profit
$57M
100.0% margin
Operating Income
$42M
74.0% margin
Net Income
$40M
70.2% margin
EPS (Diluted)
$1.93
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
$37M
Free Cash Flow
$37M
Stock-Based Comp.
$531,000
Balance Sheet
Total Assets
$119M
Total Liabilities
$119M
Stockholders' Equity
-$435,000
Cash & Equivalents
$86M
← FY 2019
All Quarters
Q1 2020 →
